Results 21 to 30 of about 2,840,103 (305)

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2023
Renal cell carcinoma with level IV tumor thrombus is a condition necessitating aggressive surgical management. Many solid organ malignancies often benefit from neoadjuvant treatments for tumor debulking and improvement of surgical outcomes.
Viraj A. Master   +7 more
doaj   +1 more source

Renal leiomyoma: An uncommon differential diagnosis of renal masses in pediatric age

open access: yesUrology Case Reports, 2021
Leiomyoma is a mesenchymal tumor which arise from any structure or organ containing smooth muscle, but is frequently seen in the female genital tract. Renal leiomyoma is extremely rare benign lesion with low incidence (1:1000), has been reported mostly ...
Derya Karabulut   +5 more
doaj   +1 more source

Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome [PDF]

open access: yes, 2013
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects one third of patients at diagnosis with a further third developing metastatic disease after extirpative surgery.
Antony C P Riddick   +25 more
core   +2 more sources

Needle tract seeding in renal tumor biopsies: experience from a single institution

open access: yesDiagnostic Pathology, 2021
Background Percutaneous needle biopsy of renal masses has been increasingly utilized to aid the diagnosis and guide management. It is generally considered as a safe procedure.
Yan Zhou   +3 more
doaj   +1 more source

A Rare Case of Neuroendocrine Tumor Following Radical Nephrectomy

open access: yesFolia Medica Indonesiana, 2022
Highlights: • Rare occurrence of a large, well-differentiated primary renal neuroendocrine tumor in a young man. • Identifying primary renal NET from the workup and histological examination of renal tumors needs to be done to understand more of this ...
Muhammad Rozaqy Ishaq   +2 more
doaj   +1 more source

Renal Tumors in the Rabbit [PDF]

open access: yesThe American Journal of the Medical Sciences, 1917
n ...
Bell,, Henrici,
openaire   +2 more sources

Nefroma mesoblastico congénito: reporte de un caso

open access: yesGaceta Médica Boliviana, 2021
El nefroma mesoblastico congénito es un tumor renal infrecuente, pero común en el periodo neonatal. De comportamiento benigno y pronóstico excelente en su variedad clásica pero en el subtipo celular puede presentar recurrencia local, invasión ...
Lorena Arze Aimaretti   +5 more
doaj  

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma [PDF]

open access: yes, 2010
Background: The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with
Johannes Hüsing   +29 more
core   +2 more sources

Sporadic angiomyolipoma of the kidney with associated renal vein tumor thrombus

open access: yesCurrent Problems in Cancer: Case Reports, 2020
Introduction: A renal angiomyolipoma (AML) is a benign kidney tumor that is most often discovered incidentally on imaging. It is generally asymptomatic, benign, and lacks the potential for invasion or metastasis.
Tanner J. Wright   +4 more
doaj   +1 more source

Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo [PDF]

open access: yes, 2013
Targeted drugs have significantly improved the therapeutic options for advanced renal cell carcinoma (RCC). However, resistance often develops, negating the benefit of these agents.
Eva Juengel   +20 more
core   +2 more sources

Home - About - Disclaimer - Privacy